In vivo, Z-guggulsterone treatment dose-dependently increased the expression level of PD-L1 in a mouse Lewis Lung Carcinoma (LLC) tumor model, with the potential to combine PD-1/PD-L1 antibodies for the treatment of NSCLC [139]. The gene discussed is CD274; the disease is neoplasm.